Biotest Aktiengesellschaft Strategic Asset Allocation Index
Biotest Aktiengesellschaft strategic asset allocation index. Biotest Aktiengesellschaft (BIO3) has a Strategic Asset Allocation Index of 148.8% as of June 2023. Strategic assets (PP&E of €555.70 Million plus long-term investments of €-) total €555.70 Million, measured against net assets of €373.50 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check BIO3 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Biotest Aktiengesellschaft (2013–2021)
Strategic asset allocation index of Biotest Aktiengesellschaft from 2013 to 2021. This chart shows how Biotest Aktiengesellschaft's Strategic Asset Allocation Index has evolved across 9 annual periods from 2013 to 2021. As of June 2023, the index stands at 148.8%, representing strategic assets of €555.70 Million against net assets of €373.50 Million EUR.
Biotest Aktiengesellschaft Strategic Asset Allocation Index by Year (2013–2021)
Biotest Aktiengesellschaft strategic asset allocation index by year from 2013 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Biotest Aktiengesellschaft from 2013 to 2021, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Biotest Aktiengesellschaft stock valuation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 125.3% | €476.70 Million | €476.70 Million | €- | €380.40 Million | ▲ +54.8 pp |
| 2020 | 70.5% | €311.30 Million | €311.30 Million | €- | €441.60 Million | ▲ +3.3 pp |
| 2019 | 67.2% | €320.30 Million | €320.30 Million | €- | €476.90 Million | ▲ +4.7 pp |
| 2018 | 62.4% | €309.10 Million | €307.20 Million | €1.90 Million | €495.20 Million | ▼ -24.1 pp |
| 2017 | 86.5% | €301.00 Million | €298.70 Million | €2.30 Million | €347.80 Million | ▲ +30.9 pp |
| 2016 | 55.7% | €200.80 Million | €196.50 Million | €4.30 Million | €360.70 Million | ▲ +0.8 pp |
| 2015 | 54.8% | €226.10 Million | €222.60 Million | €3.50 Million | €412.30 Million | ▲ +2.5 pp |
| 2014 | 52.4% | €251.40 Million | €249.90 Million | €1.50 Million | €480.20 Million | ▲ +0.5 pp |
| 2013 | 51.9% | €238.90 Million | €237.10 Million | €1.80 Million | €460.70 Million | — |